Signs and Symptoms: Pain, nausea, vomiting, itching Signs and Symptoms
Conditions
Interventions
1. 0.25% Bupivacaine
2. Saline
Sponsors
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 40 consenting patients due to undergo a laparotomy.
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be the total amount of opiate used in the intravenous patient controlled analgesia (IVPCA) in the first 48 h. . | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures will be forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) at 24 and 48 h, the number of episodes of nausea, vomiting, itching, the sedation score, and respiratory rate, the time to passage of flatus and the length of hospital stay. | — |
Countries
United Kingdom
Outcome results
None listed